Online Database of Chemicals from Around the World

3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene
[CAS# 7158-25-0]

List of Suppliers
R&D Scientific Inc. Canada Inquire  
+1 (226) 600-0236
sales@rdscientific.com
Chemical manufacturer since 2016
chemBlink standard supplier since 2023
Complete supplier list of 3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene
Identification
Name 3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene
Synonyms Pentacyclo[6.5.1.13,6.02,7.09,13]pentadeca-4,10-diene
Molecular Structure CAS # 7158-25-0, 3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene, Pentacyclo[6.5.1.13,6.02,7.09,13]pentadeca-4,10-diene
Molecular Formula C15H18
Molecular Weight 198.30
CAS Registry Number 7158-25-0
EC Number 230-512-1
SMILES C1C=CC2C1C3CC2C4C3C5CC4C=C5
Properties
Solubility 1.117 mg/L (25 ºC water)
Density 1.1±0.1 g/cm3, Calc.*
Index of Refraction 1.601, Calc.*
Melting point 52.52 ºC
Boiling Point 264.69 ºC, 287.5±40.0 ºC (760 mmHg), Calc.*
Flash Point 103.8±22.6 ºC, Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol symbol symbol   GHS02;GHS06;GHS09 Danger    Details
Hazard Statements H228-H302-H315-H319-H330-H335-H411    Details
Precautionary Statements P210-P233-P240-P241-P242-P243-P260-P264-P270-P271-P273-P280-P284-P301+P312+P330-P303+P361+P353-P304+P340+P310-P305+P351+P338-P332+P313-P337+P313-P370+P378-P391-P403+P233-P403+P235-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin sensitizationSkin Sens.1H317
SDS Available
Market Analysis Reports
List of Reports Available for 3a,4,4a,5,8,8a,9,9a-octahydro-4,9:5,8-Dimethano-1H-benz[f]indene
Related Products
(1S,3aR,6aS)-Octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester  (1S,3aR,6aS)-Octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester oxalate  (8aR,11aR)-9H-4,5,6,7,8a,10,11,11a-Octahydrocyclopenta[4,5]pyrrolo[3,2,1-jk][1,4]benzodiazepine  (8aR,11aR)-4,5,6,7,8a,10,11,11a-Octahydro-9H-cyclopenta[4,5]pyrrolo[3,2,1-jk][1,4]benzodiazepine hydrochloride  (3aalpha,5beta,6aalpha)-Octahydrocyclopenta[c]pyrrol-5-ol hydrochloride (1:1)  (Octahydrocyclopenta[c]pyrrol-4-yl)carbamic acid tert-butyl ester  4,5,6,7,9,10,11,12-Octahydro[1,4]diazepino[6,7,1-jk]carbazole  Octahydrodibenz[a,h]anthracene  (5aR,7E,11E,14aS,15S)-rel-5a,6,9,10,13,14,14a,15-Octahydro-1,3-dihydroxy-5a,9,9,12-tetramethyl-15-phenylbenzo[b]cycloundeca[e]pyran-2,4-dicarboxaldehyde  (1R,4S,5S,8R)-rel-1,2,3,4,5,6,7,8-Octahydro-1,4:5,8-dimethanoanthracene-9-carboxaldehyde  (11bS)-8,9,10,11,12,13,14,15-Octahydro-N,N-dimethyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine  Octahydro-N,N'-dimethyl-4,7-methano-1H-indene-5,?-dimethanamine  (1S,3aR,4S,8aR)-1,2,3,3a,4,5,6,8a-Octahydro-1,4-dimethyl-7-(1-methylethyl)-1,4-azulenediol  Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol  (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-Methanoazuleno[5,6-d]-1,3-dioxole  (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (3R,3aS,3bS,6aS,8aS,9aR)-Octahydro-3-hydroxy-3,8a-dimethyl-6-methylene-1H-oxireno[8,8a]azuleno[4,5-b]furan-5(6H)-one  Octahydro-3'-hydroxy-7',7'a-dimethyl-4-methylenespiro[furan-3(2H),2'-[2H]indene]-2,4'(1'H)-dione  (3aR,4S,7aR)-Octahydro-4-hydroxy-1H-indole-1-carboxylic acid 1,1-dimethylethyl ester